New Tool Enables Premier Teams to Deliver Optimized Country and Site Activation and Patient Recruitment Throughout Duration of Trial
Morrisville, N.C., July 9, 2021 — Premier Research, a leading provider of clinical research and development and advisory services to the biotechnology, specialty pharma, and medical device industry, today announced the launch of PremierPredict™, a powerful clinical trial enrollment probability simulator. Part of Premier’s Study Start-Up application, the new tool enables Premier study teams to deliver more accurate, structured, and efficient planning for country and site activation and patient recruitment – not just at the initial stages of a project, but throughout the full course of each investigational study.
“This key component of our Study Start-Up application not only alleviates uncertainty and delivers successful on-time clinical trials, but it quickly provides highly accurate patient recruitment projections,” said LaRae Bennett, Senior Director, Data & Analytics.
Monte Carlo simulation improves patient recruitment projection accuracy
The PremierPredict™ platform uses a Monte Carlo simulation to predict the probability of different outcomes. The simulator optimizes the number of sites and countries needed for each trial and estimates total country start-up, site activation, and patient recruitment needs. This is achieved by providing calculated mapping for each country, site, and patient, while considering operational variables and applying decision-making metrics that reflect trial expectations, including:
- Country start-up and regulatory process
- Site activation ramp-up
- Site fatigue
- Seasonal variation in patient enrollment
“Using PremierPredict™, our experts deliver enhanced decision-making for our sponsors with visualizations, detailed planning numbers, and project milestones that are a critical part of the services Premier Research provides,” says Bennett. “Enrollment projections can be remodeled as needed throughout the study to ensure our sponsors’ life-changing development programs stay on track.”
Learn more at https://premier-research.com/capabilities/clinical-research-development/study-start-up/.
About Premier Research
Premier Research, a clinical research and development company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.